© 2004 by the American Diabetes Association, Inc.
A Randomized Trial Evaluating a Predominantly Fetal GrowthBased Strategy to Guide Management of Gestational Diabetes in Caucasian WomenResponse to Schaefer-Graf et al.
1 Department of Diabetes, Kings College Hospital, London, U.K Address correspondence to Prof. S.A. Amiel, BSc, MD, FRCP, Kings College, Denmark Hill Campus, New Medical School Building, Bessemer Road, London SE5 9PJ, U.K. E-mail: stephanie.amiel@kcl.ac.uk
Schaefer-Graf et al. (1) rightly suggest that the management of women with gestational diabetes mellitus (GDM) should be based on more than glycemic factors alone. However, the study in which they conclude that strict glycemic control is not useful in the absence of the measurements of fetal overgrowth has two unusual features.
The authors criteria for diagnosing GDM are lower than those of the World Health Organization or the American Diabetes Association, and they may be including women who could be considered normal. This is supported by
|
| |||||||||||||||||||||||||||